Marina Kremyanskaya

3PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis.

John Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek

|Jun 29, 2023
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.

Benjamin O Adegbite, Matthew H Abramson, Victoria Gutgarts

|Aug 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.

Claire N Harrison, Vikas K Gupta, Aaron T Gerds

Pageof 1